Oxindanac (BioDeep_00000181977)
human metabolite blood metabolite
代谢物信息卡片
化学式: C17H14O4 (282.0892044)
中文名称: 羟吲达酸
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1CC2=CC(=C(C=C2C1C(=O)O)O)C(=O)C3=CC=CC=C3
InChI: InChI=1S/C17H14O4/c18-15-9-13-11(6-7-12(13)17(20)21)8-14(15)16(19)10-4-2-1-3-5-10/h1-5,8-9,12,18H,6-7H2,(H,20,21)
描述信息
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
同义名列表
数据库引用编号
8 个数据库交叉引用编号
- PubChem: 68879
- HMDB: HMDB0255985
- ChEMBL: CHEMBL2107505
- chemspider: 62111
- CAS: 99910-69-7
- CAS: 68548-99-2
- CAS: 99910-67-5
- CAS: 99910-68-6
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- J N King. Correlation between the pharmacokinetics of oxindanac and inhibition of serum thromboxane B2 in calves.
Journal of veterinary pharmacology and therapeutics.
1994 Jun; 17(3):193-201. doi:
10.1111/j.1365-2885.1994.tb00233.x
. [PMID: 7933057] - J N King, C Mauron, M J Voirol, C Le Goff, S A Hauffe. High performance liquid chromatography and pharmacokinetics of the non-steroidal anti-inflammatory drug oxindanac in calves.
Journal of veterinary pharmacology and therapeutics.
1994 Jun; 17(3):186-92. doi:
10.1111/j.1365-2885.1994.tb00232.x
. [PMID: 7933056] - J N King, C Mauron, C LeGoff, S Hauffe. Bidirectional chiral inversion of the enantiomers of the nonsteroidal antiinflammatory drug oxindanac in dogs.
Chirality.
1994; 6(6):460-6. doi:
10.1002/chir.530060603
. [PMID: 7946973] - J N King. The use of intradermal carrageenan in calves to estimate the dose of oxindanac, a nonsteroidal anti-inflammatory drug.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
1993 Oct; 57(4):215-22. doi:
NULL
. [PMID: 8269358] - L Aabakken, C K Axelsson, P B Szecsi. Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteers.
Scandinavian journal of gastroenterology.
1993 Jun; 28(6):557-60. doi:
10.3109/00365529309098266
. [PMID: 8322031] - J L Kadurugamuwa, B Hengstler, O Zak. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents.
The Journal of infectious diseases.
1989 Jan; 159(1):26-34. doi:
10.1093/infdis/159.1.26
. [PMID: 2462602] - C Tamm, L Favre, S Spence, S Pfister, M B Vallotton. Interaction of oxindanac and frusemide in man.
European journal of clinical pharmacology.
1989; 37(1):17-21. doi:
10.1007/bf00609417
. [PMID: 2687006] - E Francotte, H Stierlin, J W Faigle. Isolation and stereospecific determination of the enantiomers of oxindazac by direct liquid chromatographic resolution on triacetylcellulose.
Journal of chromatography.
1985 Oct; 346(?):321-31. doi:
10.1016/s0021-9673(00)90518-1
. [PMID: 3910671] - P H Degen, W Schneider. Simultaneous derivatisation of carboxyl and hydroxyl groups of a new antiphlogistic drug for its determination by electron-capture gas chromatography.
Journal of chromatography.
1983 Oct; 277(?):361-7. doi:
10.1016/s0378-4347(00)84859-8
. [PMID: 6643622]